Accéder directement au contenu

Identifiants chercheur

Réseaux sociaux

    Nombre de documents


    CV Xavier Thuru

    Article dans une revue27 documents

    • Jean-François Goossens, Xavier Thuru, Christian Bailly. Properties and reactivity of the folic acid and folate photoproduct 6-formylpterin. Free Radical Biology and Medicine, Elsevier, 2021, 171, pp.1-10. ⟨10.1016/j.freeradbiomed.2021.05.002⟩. ⟨hal-03226670⟩
    • Thomas Rico, Melissa Gilles, Alban Chauderlier, Thomas Comptdaer, Romain Magnez, et al.. Tau Stabilizes Chromatin Compaction. Frontiers in Cell and Developmental Biology, Frontiers media, 2021, 9, pp.740550. ⟨10.3389/fcell.2021.740550⟩. ⟨hal-03429442⟩
    • Christian Bailly, Xavier Thuru, Bruno Quesnel. Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases. Cancers, MDPI, 2021, 13 (12), pp.3034. ⟨10.3390/cancers13123034⟩. ⟨hal-03278429⟩
    • Manon Sturbaut, Fabrice Bailly, Mathilde Coevoet, Pasquale Sileo, Martine Pugniere, et al.. Discovery of a cryptic site at the interface 2 of TEAD – Towards a new family of YAP/TAZ-TEAD inhibitors. European Journal of Medicinal Chemistry, Elsevier, 2021, 226, pp.113835. ⟨10.1016/j.ejmech.2021.113835⟩. ⟨hal-03429462⟩
    • Magnez Romain, Bryan Thiroux, Morgane Tardy, Bruno Quesnel, Xavier Thuru. Measurement of Protein-Protein Interactions through Microscale Thermophoresis (MST). Bio-protocol , Bio-protocol LCC, 2020, Bio-protocol, 10 (7), ⟨10.21769/bioprotoc.3574⟩. ⟨hal-03185893⟩
    • Christian Bailly, Xavier Thuru, Bruno Quesnel. Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times. NAR Cancer, Oxford University Press, 2020, 2 (1), ⟨10.1093/narcan/zcaa002⟩. ⟨hal-02873714⟩
    • Christian Bailly, Paul-Emile Hecquet, Mostafa Kouach, Xavier Thuru, Jean-Francois Goossens. Chemical reactivity and uses of 1-phenyl-3-methyl-5-pyrazolone (PMP), also known as edaravone. Bioorganic and Medicinal Chemistry, Elsevier, 2020, 28 (10), pp.115463. ⟨10.1016/j.bmc.2020.115463⟩. ⟨hal-02873617⟩
    • Yasmine Touil, Zacharie Segaoula, Xavier Thuru, Sylvie Zouitina, Dominique Tierny, et al.. Aggressiveness potential of spontaneous canine mucosal melanoma can dictate distinct cancer stem cell compartment behaviors in regard to their initial size and expansion abilities. Stem Cells and Development, Mary Ann Liebert, In press, ⟨10.1089/scd.2019.0223⟩. ⟨hal-02873700⟩
    • Alina Ghinet, Xavier Thuru, Emilie Floquet, Joëlle Dubois, Amaury Farce, et al.. Enhanced antitumor potential induced by chloroacetate-loaded benzophenones acting as fused tubulin-pyruvate dehydrogenase kinase 1 (PDHK1) ligands. Bioorganic Chemistry, Elsevier, 2020, 96, pp.103643. ⟨10.1016/j.bioorg.2020.103643⟩. ⟨hal-02873632⟩
    • Maxime Liberelle, Romain Magnez, Xavier Thuru, Yamina Bencheikh, Séverine Ravez, et al.. MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis. Scientific Reports, Nature Publishing Group, 2019, 9 (1), ⟨10.1038/s41598-019-53099-0⟩. ⟨hal-02407901⟩
    • Emilie Floquet, Liliana Lucescu, Alina Ghinet, Sergiu Shova, Romain Magnez, et al.. Exploring isoxazoles and pyrrolidinones decorated with the 4,6‐dimethoxy‐1,3,5‐triazine unit as human farnesyltransferase inhibitors. Archiv der Pharmazie / Chemistry in Life Sciences, Wiley-VCH Verlag, 2019, 352 (5), pp.1800227. ⟨10.1002/ardp.201800227⟩. ⟨hal-02873628⟩
    • Zacharie Segaoula, Aline Primot, Frederic Lepretre, Benoit Hedan, Emmanuel Bouchaert, et al.. Isolation and characterization of two canine melanoma cell lines new models for comparative oncology. BMC Cancer, BioMed Central, 2018, 18 (1), pp.1219. ⟨10.1186/s12885-018-5114-y⟩. ⟨hal-01972446⟩
    • Floriane Gibault, Mathilde Coevoet, Manon Sturbaut, Amaury Farce, Nicolas Renault, et al.. Toward the Discovery of a Novel Class of YAP–TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP–TEAD Protein–Protein Interface. Cancers, MDPI, 2018, 10 (5), pp.140. ⟨10.3390/cancers10050140⟩. ⟨hal-02060686⟩
    • Romain Magnez, Bryan Thiroux, Solenne Taront, Zacharie Segaoula, Bruno Quesnel, et al.. PD-1/PD-L1 binding studies using microscale thermophoresis. Scientific Reports, Nature Publishing Group, 2017, 7 (1), ⟨10.1038/s41598-017-17963-1⟩. ⟨hal-02873635⟩
    • Zacharie Segaoula, Julien Leclercq, Valérie Verones, Nathalie Flouquet, Marie Lecoeur, et al.. Synthesis and Biological Evaluation of N -[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor Activity. Journal of Medicinal Chemistry, American Chemical Society, 2016, 59 (18), pp.8422-8440. ⟨10.1021/acs.jmedchem.6b00847⟩. ⟨hal-02060584⟩
    • D. Tierny, F. Serres, Z. Segaoula, I. Bemelmans, E. Bouchaert, et al.. Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma. Clinical Cancer Research, American Association for Cancer Research, 2015, 21 (23), pp.5314-5323. ⟨10.1158/1078-0432.ccr-14-3174⟩. ⟨hal-02873640⟩
    • Alina Ghinet, Benoit Rigo, Jean-Pierre Hénichart, Delphine Le Broc-Ryckewaert, Jean Pommery, et al.. Synthesis and biological evaluation of phenstatin metabolites. Bioorganic and Medicinal Chemistry, Elsevier, 2011, 19 (20), pp.6042-6054. ⟨10.1016/j.bmc.2011.08.047⟩. ⟨hal-02873643⟩
    • Samir Jawhara, Xavier Thuru, Annie Standaert‐vitse, Thierry Jouault, Serge Mordon, et al.. Colonization of Mice by Candida albicans Is Promoted by Chemically Induced Colitis and Augments Inflammatory Responses through Galectin‐3. Journal of Infectious Diseases, Oxford University Press (OUP), 2008, 197 (7), pp.972-980. ⟨10.1086/528990⟩. ⟨hal-02873647⟩
    • F Gonzalez, L Peyrin-Biroulet, C Rousseaux, Laurent Dubuquoy, Xavier Thuru, et al.. C-reactive protein (CRP), a novel adipocytokine overexpressed in mesenteric fat in Crohnʼs disease. Inflammatory Bowel Diseases, 2007, Inflammatory Bowel Diseases, 13 (5), pp.650. ⟨10.1097/00054725-200705005-00026⟩. ⟨hal-03113336⟩
    • Christel Rousseaux, Xavier Thuru, Agathe Gelot, Nicolas Barnich, Christel Neut, et al.. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Medicine, Nature Publishing Group, 2007, 13 (1), pp.35-37. ⟨10.1038/nm1521⟩. ⟨hal-02667010⟩
    • L. Peyrin-Biroulet, Xavier Thuru, C. Vignal, L. Dubuquoy, E. Merour, et al.. Peroxisome Proliferator-Activated Receptor Gamma Functions As An Antibacterial Factor. Journal of Crohn's and Colitis Supplements, 2007, 1 (1), pp.2. ⟨10.1016/s1873-9954(07)70004-6⟩. ⟨hal-02873659⟩
    • F. Gonzalez, L. Peyrin-Biroulet, C. Rousseaux, Xavier Thuru, C. Decourcelle, et al.. P176 C-Reactive Protein (crp), a novel adipocytokine overexpressed in Mesenteric fat in Crohn's disease. Journal of Crohn's and Colitis Supplements, 2007, 1 (1), pp.49. ⟨10.1016/s1873-9954(07)70188-x⟩. ⟨hal-02873662⟩
    • F. Gonzalez, L. Peyrin-Biroulet, C. Rousseaux, L. Dubuquoy, Xavier Thuru, et al.. C-reactive protein (CRP), a novel adipocytokine overexpressed in mesenteric fat in Crohnʼs disease. Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2007, 13 (supplement), pp.650. ⟨10.1097/00054725-200705001-00026⟩. ⟨hal-02873652⟩
    • Dania Chakass, David Philippe, Edmone Erdual, Sébastien Dharancy, Mathilde Malapel, et al.. micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.. Gut, BMJ Publishing Group, 2007, 56 (7), pp.974-81. ⟨10.1136/gut.2006.105122⟩. ⟨hal-00189969⟩
    • Xavier Thuru, L. Dubuquoy. PPAR as a new therapeutic target in inflammatory bowel diseases. Gut, BMJ Publishing Group, 2006, 55 (9), pp.1341-1349. ⟨10.1136/gut.2006.093484⟩. ⟨hal-02873664⟩
    • Xavier Thuru, D Philippe. Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. Gut, BMJ Publishing Group, 2006, 55 (6), pp.815-823. ⟨10.1136/gut.2005.080887⟩. ⟨hal-02873665⟩
    • Pierre Desreumaux, Xavier Thuru, David Philippe. Cannabis : des nouvelles fonctions anti-diarrhéiques et anti-cancéreuses. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, Elsevier Masson, 2004, 28 (1), pp.97. ⟨10.1016/s0399-8320(04)94859-2⟩. ⟨hal-02873668⟩

    Poster1 document

    • C. Rousseaux, Xavier Thuru, A. Gelot, N. Barnich, C. Neut, et al.. Induction of mu opioid and cannabinoid receptors by probiotics: A new mechanism of regulation of visceral pain perception. 5. Annual Advances in the Inflammatory Bowel Diseases, Dec 2006, Miami (Florida), United States. 13 (Supplement 5), pp.652-653, 2007, Abstracts from the 2006 CCFA National Research and Clinical Conference, 5th Annual Advances in the Inflammatory Bowel Diseases, Dec. 1‐3, 2006, Miami, FL. ⟨10.1097/00054725-200705001-00035⟩. ⟨hal-02873654⟩